Legal Representation
Attorney
Steven L. Nichols
USPTO Deadlines
Next Deadline
18 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
August 20, 2025
Extension Available
Until August 20, 2025
Application History
22 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 12, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 11, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Feb 11, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Feb 11, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 20, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jun 25, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 25, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jun 5, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
May 20, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
May 20, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
May 20, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 20, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
May 20, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Apr 15, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Apr 15, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Apr 15, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 10, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Apr 10, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Apr 10, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 29, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 28, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 1, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
diagnostic home testing kits consisting primarily of antibodies, buffers, and reagents to test for COVID-19, Influenza A, Influenza B, and Respiratory Syncytial Virus (RSV); diagnostic home test kits consisting primarily of antibodies, buffers, and reagents for medical purposes for disease testing, that can be purchased over-the-counter; rapid diagnostic test reagents for home use for the testing of bodily fluids for medical purposes for use in disease detection, namely, Covid-19, Influenza A, Influenza B, and Respiratory Syncytial Virus (RSV), that can be purchased over-the-counter; diagnostic medical testing reagents for home use, that can be purchased over-the-counter;
Class 010
Medical diagnostic apparatus and instruments for home use for testing for viruses, that can be purchased over-the-counter; diagnostic home testing kits consisting primarily of probes, buffers, and reagents for use in viral testing for COVID-19, Influenza A, Influenza B, and Respiratory Syncytial Virus (RSV), that can be purchased over-the-counter; diagnostic test kits for medical purposes for home use consisting primarily of probes, buffers, and reagents for use in viral testing, that can be purchased over-the-counter; medical diagnostic apparatus, namely, home-use medical testing devices for the detection of infectious diseases, that can be purchased over-the-counter
Additional Information
Pseudo Mark
FOUR SURE RAPID; FOR SURE RAPID
Classification
International Classes
005
010